CNA Financial Corporation (CNA), a Chicago-based commercial insurer majority-owned by Loews Corporation (L), has spent much of the past year trading in a broad band between the low-$40s and the mid-$50s. Its all-time high of roughly $55.62 dates back to 2017, which means a move to $60 would represent a decisive breakout into uncharted territory. That makes $60 a natural psychological milestone for investors weighing whether the stock can finally sustain new record highs.
CNA writes commercial P&C coverage across Specialty, Commercial, and International segments, serving small businesses, middle-market firms, and professional-services clients. It carries a market capitalization of roughly $13 billion and trades at a price-to-earnings (P/E) ratio of about 10 to 11, below the average of many insurance peers. The stock also offers a dividend yield of roughly 4%, supported by nine consecutive years of payout increases and periodic special dividends.
Because Loews owns approximately 90% of shares, the public float is relatively thin. That can amplify price swings in either direction, even though the stock's low beta — often cited around 0.3 — signals it tends to move less than the broader market on a day-to-day basis.
The most credible bull case rests on underwriting discipline. CNA's P&C combined ratio — a key measure where figures below 100% indicate an underwriting profit — has improved meaningfully, with the commercial segment posting what management described as a record-low combined ratio of about 90.5% in the fourth quarter of 2025. Continued premium growth, strong retention, and elevated investment income from higher-yielding fixed-income holdings all support steady earnings.
Several independent valuation models place CNA's estimated fair value well above the current price, with some discounted-cash-flow estimates reaching the high-$60s to low-$70s. If the market began rewarding CNA with a multiple closer to the peer-group average, a move toward $60 would become far more plausible even without a dramatic acceleration in earnings.
The biggest obstacle is that Wall Street is not yet on board. Bank of America Securities maintains an Underperform rating and cut its price target to $42 after a first-quarter 2026 earnings shortfall, citing higher loss-ratio forecasts. Other targets cluster in the mid-$40s to low-$50s — mostly at or below the current price — which suggests analysts see limited near-term upside rather than a breakout.
Structural headwinds also matter. Social inflation, the tendency for litigation and jury awards to push casualty claim costs higher, has pressured loss trends in lines such as commercial auto and general liability. Catastrophe losses remain an unpredictable swing factor, and insurance reserves carry inherent estimation risk. A sharp rise in claims costs or a disappointing underwriting quarter could keep the stock range-bound and delay any challenge of the all-time high.
Consensus expectations are notably cautious. Aggregated analyst price targets generally range from the low-$40s to about $53, with a median near $45–46 — below recent trading levels. This reflects a "hold"-to-"underperform" tilt rather than broad enthusiasm. In contrast, a handful of independent valuation frameworks imply upside well beyond $60. The gap between cautious sell-side targets and more optimistic fair-value estimates is itself part of the debate over whether $60 is realistic.
From a technical analysis perspective, the $55–56 zone is the defining barrier. That area marks the 2017 all-time high and the top of the stock's recent range. Any sustained push toward $60 would first require a clean breakout and hold above this level, which has repelled rallies before. On the downside, the mid-$40s has repeatedly attracted buyers and represents the nearest significant support area. A failure to hold support would undermine the case for new highs and shift the bias back toward the lower end of the range.
Traders monitoring stocks like CNA can complement their own research with tools such as Tickeron's AI Daily Buy/Sell Signals. This product uses artificial intelligence to continuously scan thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on evolving market conditions, technical behavior, and AI-driven analysis. Investors can use these signals to surface new opportunities, track existing positions, and spot shifting market trends more efficiently than manual screening alone. For those watching whether CNA can clear its long-standing resistance, AI-generated signals can offer an additional, data-driven perspective on changing momentum.
A move to $60 for CNA is ambitious but not out of reach. It would require the stock to break decisively through its all-time high near $55–56, sustain that breakout, and earn a higher valuation multiple — a combination of continued underwriting improvement, contained catastrophe losses, and renewed analyst confidence. The strongest supporting factors are disciplined underwriting, dependable capital returns, and a below-average valuation. The primary risks are cautious sell-side sentiment, social inflation in casualty lines, and unpredictable catastrophe costs. Investors should monitor quarterly combined ratios, loss-cost trends, and whether the stock can finally hold above the $55–56 resistance zone before drawing conclusions about a run toward $60.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, CNA has been closely correlated with HIG. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if CNA jumps, then HIG could also see price increases.